Thermo Fisher beat Q4 earnings and revenue estimates, driven by life sciences growth, and forecast 4%–6% revenue growth with ...
Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Thermo can mitigate the tariff issues by next year, as its scale gives it options to source ...
Zacks Investment Research on MSN
Thermo Fisher Scientific (TMO) beats Q4 earnings and revenue estimates
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.57 per share, beating the Zacks Consensus Estimate of $6.43 per share. This compares to earnings of $6.1 per share a year ago.
Thermo Fisher Scientific provides products and services that support the life sciences industry, including large pharmaceutical companies, biotechnology firms, government agencies and academic ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading ...
Thermo Fisher is well positioned as a mission-critical partner in life sciences, with a recurring revenue base and strong end-to-end solutions. The company’s strategic acquisitions and leadership in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results